Patients' views on surgeons' financial conflicts of interest

Journal of Bone and Joint Surgery

Volumn 95, Issue 2, 2013, Pages

  Camp, Mark W ^a   Mattingly, David A ^b   Gross, Allan E ^c   Nousiainen, Markku T ^d   Alman, Benjamin A ^e   McKneally, Martin F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NEW ENGLAND BAPTIST HOSPITAL   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CONFLICT OF INTEREST; FINANCIAL MANAGEMENT; HEALTH SURVEY; HUMAN; PATIENT ATTITUDE; PRIORITY JOURNAL; SURGEON; UNITED STATES;

EID: 84873668205     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.00270     Document Type: Article

References (25)

1. Surgeons for sale: conflicts and consultant payments in the medical device industry. Hearing before the Senate Special Committee on Aging; February 27, 2008; Washington D.C. http://aging.senate.gov/hearing-detail.cfm?id= 316278&. Accessed 2012 Sep 20.
2. Cooney WP 3rd. Standards of professionalism on orthopaedist-industry conflicts of interest. J Am Acad Orthop Surg. 2007 Dec;15(12):705-6.
3. Patient Protection and Affordable Care Act of 2010. Public L. 111-148, 124 Stat. 119. 2010 Mar 23.
4. AAOS Standards of Professionalism: Orthopaedic surgeon-industry relationships. http://www3.aaos.org/member/profcomp/SOPConflictsIndustry.pdf. Accessed 2012 Sep 20.
5. Pearson SD, Kleinman K, Rusinak D, Levinson W. A trial of disclosing physicians' financial incentives to patients. Arch Intern Med. 2006 Mar 27;166(6):623-8.
6. Weinfurt KP, Friedman JY, Allsbrook JS, Dinan MA, Hall MA, Sugarman J. Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med. 2006 Sep;21(9):901-6.
7. Weinfurt KP, Hall MA, King NM, Friedman JY, Schulman KA, Sugarman J. Disclosure of financial relationships to participants in clinical research. N Engl J Med. 2009 Aug 27;361(9):916-21.
8. McKneally MF. Beyond disclosure: managing conflicts of interest to strengthen trust in our profession. J Thorac Cardiovasc Surg. 2007 Feb;133(2):300-2.
9. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993 Aug 19;329(8):573-6.
10. Jacobs JJ, Galante JO, Mirza SK, Zdeblick T. Relationships with industry: critical for new technology or an unnecessary evil? J Bone Joint Surg Am. 2006 Jul;88(7): 1650-63.
11. Licurse A, Barber E, Joffe S, Gross C. The impact of disclosing financial ties in research and clinical care: a systematic review. Arch Intern Med. 2010 Apr 26; 170(8):675-82.
12. Khan MH, Lee JY, Rihn JA, Cassinelli EH, Lim MR, Kang JD, Donaldson WF 3rd. The surgeon as a consultant for medical device manufacturers: what do our patients think? Spine (Phila Pa 1976). 2007 Nov 1;32(23):2616-8; discussion 2619.
13. Strauss A, Corbin J. Grounded theory methodology: an overview. In: Denzin NK, Lincoln YS, editors. The SAGE handbook of qualitative research. Thousand Oaks: Sage; 1994. p 273-85.
14. Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med. 2006 Nov 30;355(22):2330-7.
15. Edwards D, Ballantyne A. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors. Intern Med J. 2009 Mar;39(3): 191-6.
16. Tattersall MH, Dimoska A, Gan K. Patients expect transparency in doctors' relationships with the pharmaceutical industry. Med J Aust. 2009 Jan 19;190(2):65-8.
17. Macneill PU, Kerridge IH, Newby D, Stokes BJ, Doran E, Henry DA. Attitudes of physicians and public to pharmaceutical industry 'gifts'. Intern Med J. 2010 May;40(5):335-41. Epub 2010 Mar 23.
18. Hall MA, Dugan E, Zheng B, Mishra AK. Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q. 2001;79(4): 613-39, v.
19. Dugan E, Trachtenberg F, Hall MA. Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res. 2005 Oct 3;5:64.
20. Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003 May;12(3):229-38.
21. Liu SS, Della Valle AG, Besculides MC, Gaber LK, Memtsoudis SG. Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States. Int Orthop. 2009 Jun;33(3):643-51. Epub 2008 May 7.
22. Khatod M, Inacio M, Paxton EW, Bini SA, Namba RS, Burchette RJ, Fithian DC. Knee replacement: epidemiology, outcomes, and trends in Southern California: 17,080 replacements from 1995 through 2004. Acta Orthop. 2008 Dec;79(6):812-9.
23. Canadian Institute for Health Information. Hip and Knee Replacements in Canada - Canadian Joint Replacement Registry 2008-2009 Annual Report. 2009 Jun 16. https://secure.cihi.ca/free-products/2008-cjrr-annual-report-en.pdf. Accessed 2012 Sep 20.
24. Grady C, Horstmann E, Sussman JS, Hull SC. The limits of disclosure: what research subjects want to know about investigator financial interests. J Law Med Ethics. 2006 Fall;34(3):592-9, 481.
25. Gelberman RH, Samson D, Mirza SK, Callaghan JJ, Pellegrini VD Jr. Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust. J Bone Joint Surg Am. 2010 Mar;92(3):765-77.